Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Theodoros Karantanos · SciRah

Researcher profile · Semantic Scholar

Theodoros Karantanos

Share profile

Theodoros Karantanos — researcher profile on SciRah

h-index: 16
Works: 70
Citations: 572

Most-cited papers

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden.
Theodoros Karantanos, S. Chaturvedi, Evan M. Braunstein, J. Spivak +6 more
2020Blood Advances63 citations Open access
Semantic Scholar
DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer
Ning Shen, Sovannarith Korm, Theodoros Karantanos, Dun Li +9 more
2021Communications Biology61 citations Open access
Semantic Scholar
Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia
N. Naji, Mrudula Sathish, Theodoros Karantanos
2024Cancers35 citations
Semantic Scholar
Gender-Related Differences in the Outcomes and Genomic Landscape of Patients with Myelodysplastic Syndromes/Myeloproliferative Neoplasm Overlap Syndromes
Theodoros Karantanos, Lukasz P. Gondek, R. Varadhan, A. Moliterno +3 more
2021British Journal of Haematology30 citations Open access
Semantic Scholar
Characterization of myeloproliferative neoplasms in the paediatric and young adult population
Zoey I. Harris, H. Kaizer, A. Wei, Theodoros Karantanos +6 more
2023British Journal of Haematology23 citations Open access
Semantic Scholar
The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia
Theodoros Karantanos, Patric Teodorescu, Brandy N. Perkins, I. Christodoulou +12 more
2021bioRxiv23 citations Open access
Semantic Scholar
Unraveling Venetoclax Resistance: Navigating the Future of HMA/Venetoclax-Refractory AML in the Molecular Era
Theodora Chatzilygeroudi, Theodoros Karantanos, V. Pappa
2025Cancers21 citations Open access
Semantic Scholar
Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
P. Zavras, Ilias Sinanidis, Panagiotis Tsakiroglou, Theodoros Karantanos
2023International Journal of Molecular Sciences20 citations Open access
Semantic Scholar
Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome.
Theodoros Karantanos, A. Dezern
2021Baillière's Best Practice & Research: Clinical Haematology20 citations
Semantic Scholar
Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology
Theodoros Karantanos, T. Jain, A. Moliterno, Richard J. Jones +1 more
2021International Journal of Molecular Sciences20 citations Open access
Semantic Scholar
Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance.
Theodoros Karantanos, Richard J. Jones
2019Advances in Experimental Medicine and Biology20 citations
Semantic Scholar
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine
Theodoros Karantanos, Patric Teodorescu, Marios Arvanitis, Brandy N. Perkins +14 more
2022Haematologica18 citations Open access
Semantic Scholar
Cell-specific regulation of gene expression using splicing-dependent frameshifting
Jonathan P. Ling, Alexei M. Bygrave, Clayton P. Santiago, Rogger P. Carmen-Orozco +32 more
2022bioRxiv18 citations Open access
Semantic Scholar
The roles of JAK2 in DNA damage and repair in the myeloproliferative neoplasms: Opportunities for targeted therapy.
Theodoros Karantanos, A. Moliterno
2018Blood reviews17 citations
Semantic Scholar
Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms
Margo B Gerke, I. Christodoulou, Theodoros Karantanos
2023Cancers16 citations Open access
Semantic Scholar
Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes
Breann Yanagisawa, Brandy N. Perkins, Theodoros Karantanos, M. Levis +3 more
2020Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis16 citations Open access
Semantic Scholar
Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes
Priyanka Fernandes, Natalie Waldron, Theodora Chatzilygeroudi, N. Naji +1 more
2024International Journal of Molecular Sciences15 citations Open access
Semantic Scholar
An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis
S. Karanika, James T. Gordy, Pranita Neupane, Theodoros Karantanos +14 more
2022bioRxiv14 citations Open access
Semantic Scholar
OGG1 as an Epigenetic Reader Affects NFκB: What This Means for Cancer
S. Vlahopoulos, L. Pan, L. Varışlı, Garrett M. Dancik +2 more
2023Cancers13 citations Open access
Semantic Scholar
Outcome heterogeneity of TP53-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation
Sergiu Pasca, S. Haldar, A. Ambinder, Jonathan A. Webster +13 more
2023Haematologica12 citations Open access
Semantic Scholar
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
Tania Jain, Hua-Ling Tsai, H. Elmariah, P. Vachhani +19 more
2023Haematologica11 citations Open access
Semantic Scholar
Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency
Michael J. Hochman, B. D. Smith, Theodoros Karantanos, Evan M. Braunstein +5 more
2022International journal of hematology9 citations
Semantic Scholar
Molecular and Clinical Insights into TP53-Mutated MDS and AML
Erotokritos Georgantzinos, Theodoros Karantanos
2025International Journal of Molecular Sciences7 citations
Semantic Scholar
Human Immunodeficiency Virus and Clonal Hematopoiesis
Stamatia C Vorri, I. Christodoulou, S. Karanika, Theodoros Karantanos
2023Cells7 citations Open access
Semantic Scholar
Germline ERBB2/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms
Evan M. Braunstein, Hang Chen, Felicia Juarez, Fanghan Yang +11 more
2021Cancers6 citations Open access
Semantic Scholar
DNMT3A, NPM1, and FLT3-ITD triple-mutated AML has a favorable prognosis in the era of FLT3 inhibitors
Shirley Mo, A. Ambinder, A. Dezern, B. Smith +12 more
2025Blood5 citations
Semantic Scholar
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide
Ilias Sinanidis, Michael J. Hochman, Hua-Ling Tsai, Michael P Randall +6 more
2024Bone Marrow Transplantation5 citations
Semantic Scholar
Silencing of the DNA damage repair regulator PPP1R15A sensitizes acute myeloid leukemia cells to chemotherapy
A. Bouchla, Christina D. Sotiropoulou, Christopher A Esteb, T. Loupis +11 more
2024Annals of Hematology5 citations Open access
Semantic Scholar
Development and Validation of the HIV-CARDIO-PREDICT Score to Estimate the Risk of Cardiovascular Events in HIV-Infected Patients
S. Karanika, Theodoros Karantanos, Herman A. Carneiro, Sabrina A. Assoumou
2023Cells5 citations Open access
Semantic Scholar
Inflammation exerts a nonrandom risk in the acquisition and progression of the MPN: Insights from a Mendelian randomization study
Theodoros Karantanos, H. Kaizer, S. Chaturvedi, L. Resar +1 more
2020EClinicalMedicine5 citations Open access
Semantic Scholar
C-C motif chemokine receptor-like 2 promotes the interferon-g signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53
N. Naji, Sergiu-Vlad Paşca, Theodora Chatzilygeroudi, Pablo Toledano-Sanz +29 more
2025Haematologica4 citations Open access
Semantic Scholar
Therapeutic DNA Vaccine Targeting Mycobacterium tuberculosis Persisters Shortens Curative Tuberculosis Treatment
S. Karanika, Tianyin Wang, A. Yilma, Jennie Ruelas Castillo +20 more
2024bioRxiv4 citations Open access
Semantic Scholar
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy
Jonathan A. Webster, Madison C Reed, Hua-Ling Tsai, Philip H. Imus +24 more
2025Haematologica3 citations Open access
Semantic Scholar
Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML
Andrew Zale, Venkata Preetam Sandeep Kaduluri, Jonathan A. Webster, M. Levis +11 more
2025Blood neoplasia3 citations
Semantic Scholar
Genetic determinants and genomic consequences of non-leukemogenic somatic point mutations
J. Weinstock, Sharjeel A. Chaudhry, Maria Ioannou, Maria Viskadourou +50 more
2025Nature Communications3 citations Open access
Semantic Scholar
CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia
Brandy N. Perkins, M. Showel, L. Schoch, Philip H. Imus +6 more
2022Leukemia and Lymphoma3 citations Open access
Semantic Scholar
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration
T. Jain, Hua-Ling Tsai, H. Elmariah, P. Vachhani +19 more
2023Research Square2 citations Open access
Semantic Scholar
Independent Association of Male Sex with Presentation and Clinical Outcomes in Myeloproliferative Neoplasms
Theodoros Karantanos, S. Chaturvedi, J. Spivak, Linda M. S. Resar +5 more
2018Blood2 citations Open access
Semantic Scholar
Breaking through the azacitidine plateau?—venetoclax in high-risk myelodysplastic syndrome
Yuju An, Theodoros Karantanos
2026Annals of Translational Medicine1 citations Open access
Semantic Scholar
Outcome heterogeneity in CALR-mutated myeloproliferative neoplasms.
Resham Mawalkar, Hua-Ling Tsai, Sergiu-Vlad Paşca, Lukasz P. Gondek +17 more
2026British Journal of Haematology1 citations Open access
Semantic Scholar
Evolution to complex karyotype disease in mono-allelic TP53-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study.
Priyanka Fernandes, Sergiu-Vlad Paşca, Tania Jain, Mark J. Levis +12 more
2026Haematologica1 citations Open access
Semantic Scholar
Efficacy and safety of blinatumomab for CD19+ acute leukemias in patients historically excluded from clinical trials due to comorbidities
J. Claiborne, Daniel Li, Hua-Ling Tsai, G. Ghiaur +11 more
2025Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis1 citations Open access
Semantic Scholar
Post-allogeneic hematopoietic cell transplantation outcomes are similar after hypomethylating agent/venetoclax and intensive, cytarabine-based remission induction for Acute Myeloid Leukemia when using standardized, contemporary transplant techniques
J. Claiborne, Venkata Preetam Sandeep Kaduluri, Hua-Ling Tsai, Ivana Gojo +15 more
2025Blood1 citations
Semantic Scholar
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53
N. Naji, Sergiu-Vlad Paşca, Theodora Chatzilygeroudi, Pablo Toledano-Sanz +28 more
2025bioRxiv1 citations Open access
Semantic Scholar
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML
N. Naji, Taha S. Ahmedna, J. Peske, Xinghan Zeng +20 more
2025bioRxiv1 citations
Semantic Scholar
The Genetic Determinants and Genomic Consequences of Non-Leukemogenic Somatic Point Mutations
J. Weinstock, Sharjeel A. Chaudhry, Maria Ioannou, Maria Viskadourou +51 more
2024medRxiv1 citations Open access
Semantic Scholar
Favorable Outcomes for High-Risk MDS and Oligoblastic AML with MDS-Related Changes with Reduced Intensity Allogeneic Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide
Ilias Sinanidis, Michael J. Hochman, Hua-Ling Tsai, Michael P Randall +5 more
2023Blood1 citations Open access
Semantic Scholar
Allogeneic Blood or Marrow Transplantation (BMT) with Post-Transplantation Cyclophosphamide (PTCy) Based Graft Versus Host Disease (GVHD) Prophylaxis for Myelodysplastic Syndrome/ Myeloproliferative Neoplasm-Overlap Syndromes (MDS/MPN)
Theodoros Karantanos, Hua-Ling Tsai, Lukasz P. Gondek, M. Levis +6 more
2020Blood1 citations Open access
Semantic Scholar
ATM Germline Variant Increases the Risk of MPN Progression
Theodoros Karantanos, S. Chaturvedi, C. Gocke, D. Williams +2 more
2019Blood1 citations Open access
Semantic Scholar
Abstract 5678: Cuproptosis induction in TP53-mutated acute myeloid leukemia.
Yuju An, Xinghan Zeng, Brandy N. Perkins, N. Naji +5 more
2026Cancer Research0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Dezern×19
Invite
A. Dezern — researcher profile on SciRah
A. Moliterno×12
Invite
A. Moliterno — researcher profile on SciRah
A. Ambinder×12
Invite
A. Ambinder — researcher profile on SciRah
M. Levis×11
Invite
M. Levis — researcher profile on SciRah

×9

Invite

S. Karanika — researcher profile on SciRah

Lukasz P. Gondek×8

Invite

Lukasz P. Gondek — researcher profile on SciRah

Richard J. Jones×8

Invite

Richard J. Jones — researcher profile on SciRah

Brandy N. Perkins×8

Invite

Brandy N. Perkins — researcher profile on SciRah

Jonathan A. Webster×8

Invite

Jonathan A. Webster — researcher profile on SciRah

Invite

G. Prince — researcher profile on SciRah

Invite

T. Jain — researcher profile on SciRah

Invite

G. Ghiaur — researcher profile on SciRah